Peer Review reports
From: LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
Original Submission | ||
---|---|---|
18 May 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
13 Aug 2022 | Reviewed | Reviewer Report |
19 Aug 2022 | Reviewed | Reviewer Report |
24 Aug 2022 | Reviewed | Reviewer Report |
30 Sep 2022 | Author responded | Author comments - Dongming Yan |
Resubmission - Version 3 | ||
30 Sep 2022 | Submitted | Manuscript version 3 |
11 Oct 2022 | Author responded | Author comments - Dongming Yan |
Resubmission - Version 4 | ||
11 Oct 2022 | Submitted | Manuscript version 4 |
4 Nov 2022 | Reviewed | Reviewer Report |
6 Nov 2022 | Reviewed | Reviewer Report |
10 Dec 2022 | Author responded | Author comments - Dongming Yan |
Resubmission - Version 5 | ||
10 Dec 2022 | Submitted | Manuscript version 5 |
14 Dec 2022 | Author responded | Author comments - Dongming Yan |
Resubmission - Version 6 | ||
14 Dec 2022 | Submitted | Manuscript version 6 |
10 Jan 2023 | Reviewed | Reviewer Report |
12 Jan 2023 | Reviewed | Reviewer Report |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
Publishing | ||
31 Jan 2023 | Editorially accepted | |
6 Feb 2023 | Article published | 10.1186/s12885-023-10594-y |
You can find further information about peer review here.